PT982305E - Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem - Google Patents
Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contemInfo
- Publication number
- PT982305E PT982305E PT99402092T PT99402092T PT982305E PT 982305 E PT982305 E PT 982305E PT 99402092 T PT99402092 T PT 99402092T PT 99402092 T PT99402092 T PT 99402092T PT 982305 E PT982305 E PT 982305E
- Authority
- PT
- Portugal
- Prior art keywords
- compounds
- preparation
- pharmaceutically acceptable
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9810601A FR2782515B1 (fr) | 1998-08-21 | 1998-08-21 | NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
Publications (1)
Publication Number | Publication Date |
---|---|
PT982305E true PT982305E (pt) | 2002-07-31 |
Family
ID=9529811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99402092T PT982305E (pt) | 1998-08-21 | 1999-08-20 | Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem |
Country Status (19)
Country | Link |
---|---|
US (1) | US6153625A (pt) |
EP (1) | EP0982305B1 (pt) |
JP (1) | JP2000072748A (pt) |
CN (1) | CN1128144C (pt) |
AT (1) | ATE214064T1 (pt) |
AU (1) | AU747494B2 (pt) |
BR (1) | BR9903867A (pt) |
CA (1) | CA2280596A1 (pt) |
DE (1) | DE69900961T2 (pt) |
DK (1) | DK0982305T3 (pt) |
ES (1) | ES2172294T3 (pt) |
FR (1) | FR2782515B1 (pt) |
HK (1) | HK1026212A1 (pt) |
HU (1) | HUP9902784A3 (pt) |
NO (1) | NO317516B1 (pt) |
NZ (1) | NZ337362A (pt) |
PL (1) | PL194852B1 (pt) |
PT (1) | PT982305E (pt) |
ZA (1) | ZA995321B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103646D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic chroman compounds |
AU2002217742B2 (en) * | 2001-01-16 | 2008-02-21 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
CA2434015A1 (en) * | 2001-01-16 | 2002-07-18 | Astrazeneca Ab | Therapeutic chroman compounds |
MXPA03006268A (es) * | 2001-01-16 | 2003-09-22 | Astrazeneca Ab | Compuestos terapeuticos de cromano. |
SE0103647D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic chromone compounds |
DE10142667B4 (de) | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
DE10142662B4 (de) | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel |
DE10142661B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel |
UY29892A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
FR2761358B1 (fr) * | 1997-03-27 | 1999-05-07 | Adir | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1998
- 1998-08-21 FR FR9810601A patent/FR2782515B1/fr not_active Expired - Fee Related
-
1999
- 1999-08-13 US US09/374,161 patent/US6153625A/en not_active Expired - Fee Related
- 1999-08-19 HU HU9902784A patent/HUP9902784A3/hu unknown
- 1999-08-19 JP JP11232097A patent/JP2000072748A/ja active Pending
- 1999-08-20 AT AT99402092T patent/ATE214064T1/de not_active IP Right Cessation
- 1999-08-20 NZ NZ337362A patent/NZ337362A/xx unknown
- 1999-08-20 ZA ZA9905321A patent/ZA995321B/xx unknown
- 1999-08-20 BR BR9903867-6A patent/BR9903867A/pt not_active Application Discontinuation
- 1999-08-20 DK DK99402092T patent/DK0982305T3/da active
- 1999-08-20 PT PT99402092T patent/PT982305E/pt unknown
- 1999-08-20 NO NO19994041A patent/NO317516B1/no unknown
- 1999-08-20 CN CN99119425A patent/CN1128144C/zh not_active Expired - Fee Related
- 1999-08-20 PL PL335012A patent/PL194852B1/pl not_active IP Right Cessation
- 1999-08-20 EP EP99402092A patent/EP0982305B1/fr not_active Expired - Lifetime
- 1999-08-20 ES ES99402092T patent/ES2172294T3/es not_active Expired - Lifetime
- 1999-08-20 CA CA002280596A patent/CA2280596A1/fr not_active Abandoned
- 1999-08-20 AU AU44637/99A patent/AU747494B2/en not_active Ceased
- 1999-08-20 DE DE69900961T patent/DE69900961T2/de not_active Expired - Fee Related
-
2000
- 2000-09-04 HK HK00105538A patent/HK1026212A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2280596A1 (fr) | 2000-02-21 |
ES2172294T3 (es) | 2002-09-16 |
HUP9902784A3 (en) | 2001-03-28 |
JP2000072748A (ja) | 2000-03-07 |
US6153625A (en) | 2000-11-28 |
NO317516B1 (no) | 2004-11-08 |
PL335012A1 (en) | 2000-02-28 |
FR2782515A1 (fr) | 2000-02-25 |
AU747494B2 (en) | 2002-05-16 |
EP0982305B1 (fr) | 2002-03-06 |
BR9903867A (pt) | 2000-09-05 |
AU4463799A (en) | 2000-03-09 |
CN1250051A (zh) | 2000-04-12 |
ATE214064T1 (de) | 2002-03-15 |
DE69900961T2 (de) | 2002-11-07 |
DK0982305T3 (da) | 2002-06-24 |
NO994041L (no) | 2000-02-22 |
NO994041D0 (no) | 1999-08-20 |
CN1128144C (zh) | 2003-11-19 |
FR2782515B1 (fr) | 2000-09-22 |
HUP9902784A2 (hu) | 2000-12-28 |
PL194852B1 (pl) | 2007-07-31 |
NZ337362A (en) | 2000-04-28 |
ZA995321B (en) | 2000-02-22 |
HK1026212A1 (en) | 2000-12-08 |
DE69900961D1 (de) | 2002-04-11 |
EP0982305A1 (fr) | 2000-03-01 |
HU9902784D0 (en) | 1999-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400250A2 (hu) | 5-HT6 és/vagy 5-HT7 szerotonin receptorok ligandumaként alkalmazott 5-halogén-triptamin-származékok, előállításuk és alkalmazásuk gyógyszerkészítmények előállítására | |
HUP0101146A2 (hu) | Foszfolipáz enzim inhibitor hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyászati készítmények | |
DK0705254T3 (da) | Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer | |
DK0794949T3 (da) | Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler | |
EA200500018A1 (ru) | Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения | |
BR9812046A (pt) | Compostos, processos para a preperação do composto e para tratar um paciente humano ou animal, composição farmacêutica, e, uso de um composto | |
TR200001973T2 (tr) | 11 ß-halojen-7alfa-ile ikame edilmiş-estratrienler, bu 11ß-halojen-7alfa-ile ikame edilmiş-estratrienleri içeren farmasötik terkiplerin üretimi için yöntem ve ilaç üretiminde kullanımları. | |
ATE52498T1 (de) | Amidderivate. | |
BR0015195A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma condição associada com a transmissão reduzida de nicotina para o tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para o tratamento ou profilaxia de doenças ou condições humanas | |
FR2800735B1 (fr) | Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation | |
PT982305E (pt) | Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem | |
EE200200591A (et) | Püridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks ühenditeks | |
DK1109560T3 (da) | Som AICARFT-inhibitorer anvendelige forbindelser | |
HUP0300295A2 (hu) | Helyettesített benzamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP9902199A1 (hu) | Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények | |
HUT59124A (en) | Process for producing 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane derivatives and pharmaceutical compositions comprising such derivatives as active ingredient | |
ITMI20042475A1 (it) | Uso di derivati tiazolidinonici come agenti terapeutici | |
EA200101109A1 (ru) | Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана | |
SE9900190D0 (sv) | New compounds | |
HUP0003856A2 (hu) | 6-Pirrolidin-2-ilpirindin-származékok, eljárás előállításukra és gyógyászati alkalmazásuk | |
NO20023381D0 (no) | Indolderivater som MCP-1-reseptoragonister | |
DK601783A (da) | Resorcinderivater | |
SE0100344D0 (sv) | New Use | |
HUP0100750A2 (hu) | Új 6-szulfamoil-3-kinolilfoszfonsav származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
SE8500963D0 (sv) | Nitraminodiaryl sulfoxide derivatives, process for their preparation and pharmaceutical and pesticidal compositions containing them |